4 results
Approved WMOPending
Primary ObjectiveTo determine the incidence and grading of infusion related/hypersensitivity reactions reported per drug using the definition of Common Terminology Criteria for Adverse Events (CTCAE) criteria for: infusion related reaction during…
Approved WMORecruiting
To determine the real-world pharmacokinetics of ICIs.
Approved WMORecruiting
The evaluation of R-IrAE's after ICI therapy, specifically incidence, treament of R-IrAE's, response to said treatment, baseline and follow-up serology (general and symptom specific) to be combined with quality of life assessment and…
Approved WMOPending
• To evaluate the efficacy of treatment• To evaluate the safety of treatment